Sort
130,381 grants matching “hiv”
Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV
$805,787Canhua Xiao · Emory University · R01 · FY2022 · DE
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study
$805,749Laurence Huang · University Of California, San Francisco · U01 · FY2010 · HL
Cocaine use, viral suppression and precursors of stroke in HIV infection
$805,697Elise D Riley · University Of California, San Francisco · R01 · FY2020 · DA
Allosteric Modulators of Dopamine Transporter as Therapeutic Agents for NeuroAIDS
$805,690Corinne Elizabeth Augelli-Szafran · Southern Research Institute · R01 · FY2020 · DA
TAMPA BAY ADOLESCENT MEDICINE TRIALS UNIT
$805,685University Of South Florida · U01 · FY2005 · HD
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV
$805,684Natalia Teleshova · Population Council · R01 · FY2024 · AI
Next Generation Broadly Neutralizing Antibodies to Clear HIV-1 Reservoir
$805,652Yuxing Li · University Of Maryland Baltimore · R01 · FY2019 · AI
Spatiotemporal Staging of the HIV-1 Preintegration complex
$805,630Chandravanu Dash · Meharry Medical College · R01 · FY2023 · AI
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
$805,578Kenneth W Witwer · Johns Hopkins University · R01 · FY2020 · AI
Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs
$805,568Michael Kevin Riscoe · Oregon Health & Science University · R01 · FY2022 · AI
THE GENERALIZABILITY OF HIV RISK REDUCTION STRATEGIES
$805,567University Of Pennsylvania · R01 · FY2003 · HD
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION
$805,514Weill Medical College Of Cornell Univ · R01 · FY2003 · DA
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity
$805,483James A Hoxie · University Of Pennsylvania · R01 · FY2018 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$805,377Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Influence of maternal virome and HIV status on infant gut virome, growth and immunity
$805,358Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2020 · HD
Role of Macrophages in Lung Disease Pathogenesis of Pediatric AIDS
$805,346Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2017 · HL
Determining the relative contribution of CD4 T cells and macrophages to HIV persistence and rebound
$805,328Mirko Paiardini · Emory University · R01 · FY2020 · MH
Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)
$805,326Jose Gutierrez · Columbia University Health Sciences · R01 · FY2024 · AG
Innovative therapeutic strategies to support elimination of river blindness
$805,271Makedonka Mitreva · Washington University · R01 · FY2024 · AI
PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis
$805,259Jared Baeten · University Of Washington · R01 · FY2021 · AI
HIV Prevention Within High-Risk Social Networks
$805,237Jeffrey A. Kelly · Medical College Of Wisconsin · R01 · FY2006 · MH
Cocaine use, viral suppression and precursors of stroke in HIV infection
$805,233Elise D Riley · University Of California, San Francisco · R01 · FY2022 · DA
DENVER COMMUNITY PROGRAM FOR CLINICAL RESEARCH ON AIDS (
$805,209Denver Health And Hospital Authority · U01 · FY2004 · AI
Antiviral agents directed to novel targets in the adenovirus proteinase
$805,153Walter F. Mangel · Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2008 · AI
Southern California Primary Infection Program
$805,095University Of California San Diego · U01 · FY2003 · AI